Status
Conditions
About
The survey is conducted to collect safety and effectiveness information targeting patients who have both Parkinson's disease and renal dysfunction treated with Pramipexole in the daily clinical settings in Japan.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients with Parkinson's disease who have renal dysfunction with pretreatment creatinine clearance =<70mL/min or whose renal dysfunction was determined by the physician
Exclusion criteria
None
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal